4//SEC Filing
Fernandes Peter 4
Accession 0001415889-23-002459
CIK 0001600132other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:46 PM ET
Size
5.4 KB
Accession
0001415889-23-002459
Insider Transaction Report
Form 4
Fernandes Peter
Chief Regulatory Officer
Transactions
- Award
Stock Options (right to buy)
2023-02-10$1.52/sh+100,000$152,000→ 100,000 totalExercise: $1.52Exp: 2033-02-10→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]This option vests as to 25% of the underlying shares on February 10, 2024 and the remaining options vest quarterly over a period of 3 years thereafter.
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeother
Related Parties
1- filerCIK 0001642618
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:46 PM ET
- Size
- 5.4 KB